Cognex Corp (CGNX) Tops Q3 EPS by 5c; Guides Q4 Sales
Tweet
Share
E-mailGet Alerts CGNX Hot Sheet
Price: $61.59 +1.52%
Financial Fact:
Selling, general, and administrative expenses: 42.07M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general, and administrative expenses: 42.07M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cognex Corp (NASDAQ: CGNX) reported Q3 EPS of $0.42, $0.05 better than the analyst estimate of $0.37. Revenue for the quarter came in at $80.1 million versus the consensus estimate of $80.01 million.
Sees Q4 2011 revenue of $80-$83 million, versus the consensus of $85.4 million.
Sees Q4 2011 revenue of $80-$83 million, versus the consensus of $85.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cognex (CGNX) PT Raised to $65 at DA Davidson
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
